Odense, Denmark · Founded 2014 · Privately Held (backing)
Developer of a 3D cell culture technology designed to grow cells so that they retain or recover their in vivo physiological attributes. Celvivo is based in Odense, Denmark and was founded in 2014. Its last reported valuation was $25.7 million in May 2025. It has raised $10.9 million.
Last reported valuation
$25.7M
Oct 2026
Priced at
—
Total raised
$10.9M
Last round
—
Cap table — not yet on record
Celvivo's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Celvivo with a free account
·Watch Celvivo: the Monday email on marks, rounds and moves
